Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Immunotherapy for myasthenia gravis: A murine model
P. Christadoss, M. J. Dauphinee
Research output
:
Contribution to journal
›
Article
›
peer-review
122
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunotherapy for myasthenia gravis: A murine model'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Murine Model
100%
Monoclonal Antibody
100%
Myasthenia Gravis
100%
Experimental Autoimmune Myasthenia Gravis
75%
Helper T-lymphocytes
75%
Autoimmunity
50%
Acetylcholine Receptor (AChR)
50%
Immunotherapeutics
50%
T Cell Response
25%
Muscle Weakness
25%
Clinical Disease
25%
MHC Class II
25%
Remission
25%
In Vivo Applications
25%
Muscle Acetylcholine Receptor
25%
Collagen-induced Arthritis
25%
Major Histocompatibility Complex Molecules
25%
Major Histocompatibility Complex Genes
25%
Autoimmune Encephalitis
25%
Glycoprotein Antigen
25%
Murine Lupus
25%
Medicine and Dentistry
Monoclonal Antibody
100%
Immunotherapy
100%
Myasthenia gravis
100%
T Lymphocyte
75%
Cholinergic Receptor
75%
Experimental Autoimmune Myasthenia Gravis
75%
Immunomodulating Agent
50%
Autoimmunity
50%
Major Histocompatibility Complex
50%
Disease
25%
T-Cell Response
25%
Glycoprotein
25%
Lupus Erythematosus
25%
Muscle Weakness
25%
Allergic Encephalomyelitis
25%
Collagen-Induced Arthritis
25%
Immunology and Microbiology
Monoclonal Antibody
100%
Myasthenia gravis
100%
Immunotherapy
100%
T Helper Cell
75%
Experimental Autoimmune Myasthenia Gravis
75%
Immunology
75%
Immunomodulating Drugs
50%
Autoimmunity
50%
Major Histocompatibility Complex
50%
T Cell
25%
Glycoprotein
25%
Lupus Erythematosus
25%
Murine
25%
Arthritis
25%
Allergic Encephalomyelitis
25%